Home  /  Resource Library  /  Atrial fibrillation (AF) in patients with CLL treated with ibrutinib: Assessing prediction models and clinical outcomes

Atrial fibrillation (AF) in patients with CLL treated with ibrutinib: Assessing prediction models and clinical outcomes

ASCO 2019: Article discusses a new risk score to accurately predict atrial fibrillation among patients treated with ibrutinib for chronic lymphocytic leukemia.